GTS Securities’s Quest Diagnostics DGX Stock Holding History
Bought
Maintained
Sold
Other funds holding DGX
GTS Securities's DGX Position: Q3 2026 in Review
GTS Securities opened a new position in Quest Diagnostics (DGX) in Q3 2026: 894 shares worth $208K. The stake represents ﹤0.01% of the portfolio and ranks #1525 among its holdings. This is a return to the name: GTS Securities previously reported a position in DGX as recently as Q4 2025.
GTS Securities first reported a position in DGX in Q4 2023 and has held it in 7 quarters since. The position peaked at $776K in Q1 2024. 1,126 funds tracked by Wall St. Rank hold DGX as of Q3 2026.
- GTS Securities held 894 shares of Quest Diagnostics worth $208K as of Q3 2026.
- Quest Diagnostics was a new GTS Securities position in Q3 2026.
- Quest Diagnostics made up ﹤0.01% of GTS Securities's portfolio in Q3 2026, its #1525 holding.
- GTS Securities first reported a position in Quest Diagnostics in Q4 2023 and has held it in 7 quarters since.
- GTS Securities's Quest Diagnostics position peaked at $776K in Q1 2024.
- 1,126 funds tracked by Wall St. Rank held Quest Diagnostics as of Q3 2026.
Based on GTS Securities's 13F filing for Q3 2026, filed 16 Nov 2026.